Skip to content

Now that I have a better understanding of the model and the biological context, I'll provide a comprehensive review of GO-CAM model gomodel:66f5faaa00001204 (Retinoid Metabolic Process 1 in Mouse).

Review of GO-CAM Model: Retinoid Metabolic Process 1 (Mouse)

Model ID: gomodel:66f5faaa00001204

Overall Assessment

This GO-CAM model represents retinoid (vitamin A) metabolic processes in mouse. It includes key enzymes involved in retinoid transport, binding, metabolism, and storage. The model captures the flow of retinol metabolism through various activities including hydrolysis, transport, oxidation, and esterification within the retinoid metabolic pathway.

Strengths

  1. The model correctly represents "retinoid metabolic process" (GO:0001523) as the overarching biological process, with individual molecular activities properly identified as part of this process.

  2. The causal connections between activities use appropriate predicates, generally following the flow of the retinoid metabolic pathway.

  3. Molecular function assignments are well-supported by literature evidence (ECO codes are appropriate and include references to primary literature).

  4. The model correctly represents cellular localization of different activities (e.g., extracellular region, plasma membrane, endoplasmic reticulum membrane, cytosol).

  5. Chemical entities (CHEBI terms) are appropriately used to represent the molecular inputs and outputs of the different enzymatic reactions.

Issues and Recommendations

1. Complex Annotation

The model includes GO:0042627 (chylomicron) as a protein complex enabling the retinoid binding activity (GO:0005501), but no members of this complex are specified:

"id":"gomodel:66f5faaa00001204/66f5faaa00001265",
"enabled_by":{"type":"EnabledByProteinComplexAssociation","term":"GO:0042627","members":[]}

According to "How to annotate complexes in GO-CAM," when a complex is used, it should either include the subunits that carry the activity (if known) or use the GO complex term if the specific protein carrying the activity is not known. In this case, the specific proteins in the chylomicron that bind retinoids should be specified if known, or a note should be included explaining why the complex is used without specified members.

2. Molecular Carrier Activity

The model correctly uses molecular carrier activity (GO:0140104) for Rbp2 (MGI:MGI:97877), but this should be carefully reviewed to ensure it follows the guidelines for molecular carrier activity:

  • The model correctly uses "has_primary_input" to indicate all-trans-retinol (CHEBI:17336), but it's not clear if appropriate downstream connections are made to show where the carried molecule is delivered.

3. Completeness of Evidence

Some activities lack evidence codes or citations: - The chylomicron retinoid binding activity (gomodel:66f5faaa00001204/66f5faaa00001265) lacks evidence annotations. - Several causal associations lack evidence codes.

I recommend adding evidence codes and references for all assertions to strengthen the model's validity.

4. Biological Completeness

While the model captures key aspects of retinoid metabolism, some known components of the pathway might be missing: - Cellular retinol-binding protein (CRBP) and cellular retinoic acid-binding protein (CRABP) which are important intracellular carriers are not explicitly represented. - The conversion of retinol to retinoic acid (via retinal) is represented but could be more detailed with the specific steps and enzymes involved.

5. Causal Association and Activity Flow

Some improvements could be made in the representation of causal relationships: - The model has both Rbp1 (MGI:MGI:97876) activities (gomodel:66f5faaa00001204/66f5faaa00001280 and gomodel:66f5faaa00001204/66f5faaa00001307) inhibiting Adh1 (MGI:MGI:87921) retinol dehydrogenase activity. Based on the PMID:15193143 reference, this appears to represent the opposing actions of CRBP1 (Rbp1) and ADH1 in regulating the balance between retinyl ester formation and retinol oxidation. This is biologically accurate and well-represented.

  • The causal relationships across the entire model create a coherent flow that aligns with the known retinoid metabolic pathway.

Specific Entity Reviews

Enzymes and Their Functions

  1. Lpl (MGI:MGI:96820) - Lipoprotein lipase activity: Correctly represented as participating in retinoid metabolic process and occurring in extracellular region.

  2. Lrat (MGI:MGI:1891259) - O-palmitoyltransferase and phosphatidylcholine-retinol O-acyltransferase activities: Both activities are correctly represented as occurring in ER membrane.

  3. Rbp1 (MGI:MGI:97876) and Rbp2 (MGI:MGI:97877) - Retinol binding and molecular carrier activities: Appropriately represented with their respective molecular functions.

  4. Pnlip (MGI:MGI:97722) - Retinyl-palmitate esterase activity: Correctly shown occurring in the extracellular region with appropriate inputs and outputs.

  5. Adh1 (MGI:MGI:87921) - Retinol dehydrogenase activity: Properly represented with appropriate regulation by Rbp1.

Conclusion

Overall, this GO-CAM model provides a good representation of the retinoid metabolic process in mouse. It captures the key activities and relationships in the pathway, with strong evidence support. The model would benefit from a few clarifications around complex representation and the addition of evidence codes for all assertions. The biological content is accurate and consistent with the literature. The connections between activities represent the known flow of the retinoid metabolic pathway reasonably well.

The model is parsimonious and focused on the core aspects of retinoid metabolism, making it accessible and understandable while still being comprehensive. With the minor improvements suggested, this would be an excellent curated model of retinoid metabolism.